Showing results (1051-1060 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|April 23, 2017
Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic ReviewMarina Dyskant Mochcovitch, Rafael Christophe da Rocha Freire, Rafael Ferreira Garcia, et al.
Clinical Drug Investigation|April 15, 2017
Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical TrialsVinicius L Ferreira, Fernanda S Tonin, Nayara A Assis Jarek, et al.
Clinical Drug Investigation|April 3, 2019
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the RevolutionVeronica Mollica, Vincenzo Di Nunno, Lidia Gatto, et al.
Clinical Drug Investigation|January 26, 2017
Pharmacokinetic Profile and Tolerability of Liposomal Bupivacaine Following a Repeated Dose via Local Subcutaneous Infiltration in Healthy VolunteersDavid Rice, Justin W Heil, Lukasz Biernat
Clinical Drug Investigation|June 12, 2008
Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational studyPedro Gil, José Luis Dobato Ayuso, José Manuel Marey, et al.
Clinical Drug Investigation|March 18, 2017
Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United StatesApril W Armstrong, J Will Koning, Simon Rowse, et al.
Clinical Drug Investigation|May 8, 2014
Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjectsMin Kyu Park, Tae-Eun Kim, JaeWoo Kim, et al.
Clinical Drug Investigation|March 16, 2021
Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover StudyJocelyn Y Cheng, Margaret Moline, Gary K Zammit, et al.
Clinical Drug Investigation|November 6, 2021
Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical StudyNarcís Cardoner, Antoni Sicras-Mainar, Javier Rejas, et al.
Clinical Drug Investigation|November 15, 2021
Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection FractionAhmed S Elserafy, Ashraf Reda, Elsayed Farag, et al.
Pageof 234